Research increasingly shows that physical activity, particularly a combination of strength training and cardiovascular exercise, plays an important role in supporting overall health, preserving muscle mass, increasing bone health, and improving long-term outcomes while using these medications
Unlike insurance claims data, which tend to reflect usage among diabetic or obese patients with treatment covered by insurance, Numerators data also capture households that use GLP-1 drugs off-label, including many who pay out of pocket and do not meet the clinical criteria for obesity, providing a broader view of adoption patterns
The National Institutes of Health provides resources on recognizing overtraining syndrome and its relationship to inadequate recovery
Studies have found that the majority of people who start taking GLP-1s stop taking them within a year, and after stopping, about half begin to take the drug again